In addition, I have recommended that the Ministry centrally monitor the number of patients receiving drugs under the New Drug Funding Program, the duration of treatment and the expenses associated with the funding. [...] In the case of Avastin, the funding limit flies in the face of the acceptable standard of oncology practice in this province and beyond. [...] Among the amendments was the introduction of the following set of guiding principles for the public drug system: 1. The public drug system aims to meet the needs of Ontarians, as patients, consumers and taxpayers. [...] The Subcommittee considers the clinical efficacy and safety, the standard of care, and the cost effectiveness of the drug (i.e. [...] At present, the Subcommittee advises the Committee to Evaluate Drugs of the results of its evaluation, and the Committee, in turn, makes a recommendation to the Executive Officer regarding funding.
health cancer health insurance medicine health care colorectal neoplasms therapy clinical trial antibodies, monoclonal chemotherapy clinical medicine medicare healthcare policy drug health treatment health sciences clinical government health care medical drugs clinical trials medical treatments bevacizumab colorectal cancer rectum colon (anatomy) pharmaceutical drug metastatic colorectal cancer avastin erbitux first-line treatment